DE69916629D1 - Taurolidin und/oder taurultam zur behandlung von infektiösen ulcera oder gastritis - Google Patents

Taurolidin und/oder taurultam zur behandlung von infektiösen ulcera oder gastritis

Info

Publication number
DE69916629D1
DE69916629D1 DE69916629T DE69916629T DE69916629D1 DE 69916629 D1 DE69916629 D1 DE 69916629D1 DE 69916629 T DE69916629 T DE 69916629T DE 69916629 T DE69916629 T DE 69916629T DE 69916629 D1 DE69916629 D1 DE 69916629D1
Authority
DE
Germany
Prior art keywords
taurolidin
ulcera
taurultam
gastritis
treating infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69916629T
Other languages
English (en)
Other versions
DE69916629T2 (de
Inventor
Rolf Pfirrmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Publication of DE69916629D1 publication Critical patent/DE69916629D1/de
Application granted granted Critical
Publication of DE69916629T2 publication Critical patent/DE69916629T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
DE69916629T 1998-09-16 1999-09-13 Taurolidin und/oder taurultam zur behandlung von infektiösen ulcera oder gastritis Expired - Lifetime DE69916629T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15445198A 1998-09-16 1998-09-16
US154451 1998-09-16
US09/316,115 US6117868A (en) 1998-09-16 1999-05-20 Treatment of gastrointestinal ulcers or gastritis caused by microbial infection
US316115 1999-05-20
PCT/GB1999/003030 WO2000015232A1 (en) 1998-09-16 1999-09-13 Taurolidine and/or taurultam against infectious ulcer or gastritis

Publications (2)

Publication Number Publication Date
DE69916629D1 true DE69916629D1 (de) 2004-05-27
DE69916629T2 DE69916629T2 (de) 2004-08-12

Family

ID=26851461

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69916629T Expired - Lifetime DE69916629T2 (de) 1998-09-16 1999-09-13 Taurolidin und/oder taurultam zur behandlung von infektiösen ulcera oder gastritis

Country Status (8)

Country Link
US (1) US6117868A (de)
EP (1) EP1112074B1 (de)
JP (1) JP4981208B2 (de)
CA (1) CA2344308C (de)
DE (1) DE69916629T2 (de)
ES (1) ES2219061T3 (de)
RU (1) RU2227033C2 (de)
WO (1) WO2000015232A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8304390B2 (en) * 1997-07-31 2012-11-06 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treatment for preventing or reducing tumor growth in the liver of patient
US20050124608A1 (en) * 2001-04-03 2005-06-09 Redmond H. P. Treatment of cancers
US7892530B2 (en) * 1999-06-04 2011-02-22 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
US8030301B2 (en) * 1999-06-04 2011-10-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
US7345039B2 (en) * 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
JP2001122777A (ja) * 1999-10-27 2001-05-08 Nagase & Co Ltd 抗潰瘍剤
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
ES2531547T3 (es) 1999-12-06 2015-03-17 Geistlich Pharma Ag Uso de taurolidina o el taurultamo para la fabricación de un medicamento para el tratamiento de tumores
FR2803206A1 (fr) * 1999-12-30 2001-07-06 Aventis Pharma Sa Composition comprenant des acides nucleiques, preparation et utilisation
US6365198B1 (en) * 2001-01-28 2002-04-02 Gulf Pharmaceutical Industries Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids
CA2462564C (en) 2001-10-01 2012-07-10 Rhode Island Hospital Methods of inhibiting metastases
FI20021819A0 (fi) * 2002-10-14 2002-10-14 Pekka Untamo Heino Valmiste alkoholin metabolian tehostamiseksi
JP2007537200A (ja) * 2004-05-14 2007-12-20 ハンス−ディートリヒ・ポラシェグ タウロリジン製剤及び投与：細菌マイクロフィルム形成に対する治療処置及び抗菌保護
CN101365463B (zh) * 2006-12-20 2010-12-08 协和化学工业株式会社 抗酸剂
RU2410100C2 (ru) 2009-03-30 2011-01-27 Александр Владимирович Диковский Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки
EP2538945A4 (de) * 2010-02-24 2013-07-24 Emisphere Tech Inc Orale b12-therapie
EP2601947A1 (de) * 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Kombinationspräparat mit fester Dosierung zur Behandlung von Erkrankungen einhergehend mit Helicobacter pylori
ES2644870T3 (es) 2012-06-18 2017-11-30 Geistlich Pharma Ag Derivados de oxatiazina como agentes antibacterianos y anticancerígenos
CA3000868A1 (en) * 2015-10-07 2017-04-13 Cormedix Inc. Skin-penetrating formulation of taurolidine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124285A (en) * 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
GB8617482D0 (en) * 1986-07-17 1986-08-28 Geistlich Soehne Ag Pharmaceutical composition
GB9005856D0 (en) * 1990-03-15 1990-05-09 Geistlich Soehne Ag Compositions
TW276996B (de) * 1992-04-24 1996-06-01 Astra Ab
JPH09121890A (ja) * 1995-10-30 1997-05-13 Mitsubishi Kagaku B C L:Kk ヘリコバクター属細菌の検出方法
JPH1017471A (ja) * 1996-07-04 1998-01-20 Yoshitomi Pharmaceut Ind Ltd ピリジン化合物系併用医薬
JP3677376B2 (ja) * 1996-08-13 2005-07-27 武田薬品工業株式会社 医薬
US5972933A (en) * 1998-01-08 1999-10-26 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating microbial infections

Also Published As

Publication number Publication date
RU2227033C2 (ru) 2004-04-20
CA2344308C (en) 2008-05-20
EP1112074B1 (de) 2004-04-21
CA2344308A1 (en) 2000-03-23
JP4981208B2 (ja) 2012-07-18
JP2002525266A (ja) 2002-08-13
US6117868A (en) 2000-09-12
DE69916629T2 (de) 2004-08-12
WO2000015232A1 (en) 2000-03-23
ES2219061T3 (es) 2004-11-16
EP1112074A1 (de) 2001-07-04

Similar Documents

Publication Publication Date Title
DE69916629D1 (de) Taurolidin und/oder taurultam zur behandlung von infektiösen ulcera oder gastritis
DE69704877D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
ATE230617T1 (de) Verfahren und methode zur behandlung von abfällen
ATE477270T1 (de) Verfahren und zusammensetzungen zur prävention und behandlung von anämie
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE69910781D1 (de) Behandlung zur beseitigung von gerüchen
DE69733329D1 (de) Verwendung von Taurin zur Behandlung oder Vorbeugung von ischämischen Verletzungen
DE69806579T2 (de) Anlage zur behandlung von nahrungsmitteln
DE69733720D1 (de) Mobile anordnung und prozess zur behandlung von infektiosem abfall
DE59806619D1 (de) Oxidationsverfahren und anlage zur behandlung von abwässern
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
DE69905616D1 (de) Verfahren und zusammensetzung zur behandlung und vorbeugung von mycobacterium infektionen
DE69936251D1 (de) Mittel zur vorbeugung und linderung der periodontose
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
DE29808006U1 (de) Sprühvorrichtung zur Behandlung von Schnitt- und Fräskanten
DE69941821D1 (de) Fluorenthaltende zusammensetzung zur behandlung von oberflächen
DE69716896T2 (de) Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression
DE69900168D1 (de) Zusammensetzung zur Behandlung von Papier und damit behandeltes Papier
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69721756D1 (de) Paroxetine zur behandlung von depression
DE69900339T2 (de) Mittel und Verfahren zur Behandlung von Kunstfasern
DE69926485D1 (de) Behandlung von durchblasgasen
ATE433323T1 (de) Verwendung von erythropoietin zur behandlung von primärer hämochromatosen
DE69930725D1 (de) Verfahren und kits zur behandlung von vulvovaginalen candidosen mit mikonazolnitrat
DE69928501D1 (de) Mittel zur vorbeugung/behandlung von osteoporose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition